ELOVL5 and posterior cortical atrophy: Consistent with the PUFA elevation, we also found that ELOVL5 was overexpressed in enzalutamide-resistant PCa cells and modulating ELOVL5 expression did alter the enzalutamide resistance of NE-like PCa cells as well as the neuroendocrine characteristics.